MAP2K1 and neoplasm: The underlying mechanism involves the competitive interaction of cNFIB with mitogen-activated protein kinase kinase1 (MEK1), resulting in the dissociation of MEK1, and mitogen-activated protein kinase 2 (ERK2), ultimately suppressing ERK signaling and tumor metastasis.